The results were predictable
Oral forms like Rybelsus, however, do not require refrigeration and can be stored at room temperature
Obesity experts told the AP , however, that up to 20 percent or one in every five patients may not lose weight on the drugs at all
Garvey WT, Frias JP, Jastreboff AM et al (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Research shows that plateaus typically occur when patients reach approximately 1015% of their starting body weight loss, suggesting a biological threshold rather than treatment failure
Weeks 1 to 4: the 0.25 mg phase This is the introductory dose